BIOMEBANK
BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat Clostridoides difficile, a potentially life threatening infection, and are positioning the drug product for multiple indications. Furthermore, we are actively developing second generation therapies in multiple diseases, including Ulcerative Colitis and Crohn's Disease.
BIOMEBANK
Industry:
Biopharma Biotechnology Manufacturing
Founded:
2018-01-01
Address:
Adelaide, South Australia, Australia
Country:
Australia
Total Employee:
11+
Status:
Active
Contact:
08 8152 9370
Similar Organizations
Amino Medical Science
Amino Medical Science is a clinical stage biotechnology company that pioneers first-in-class therapeutic treatments
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
miRecule
MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics.
Founder
More informations about "BiomeBank"
The Team - Biome Bank
BiomeBank is made up of a team of drug development experts based in a new world-class cGMP manufacturing facility in the heart of Adelaide’s medical precinct. Our team has published …See details»
Ellerston - Biome Bank
Introducing BiomeBank BiomeBank is a clinical-stage biotechnology company that aims to treat and prevent disease by restoring gut microbial ecology. (1:40) What is the Consortiome …See details»
BiomeBank - Crunchbase Company Profile & Funding
BiomeBank is a clinical stage biotechnology company developing microbial therapies to restore human gut microbial ecology. BIOMICTRA,TM is the first approved donor derived microbiome therapy in the world (approved by TGA in …See details»
BiomeBank - Org Chart, Teams, Culture & Jobs - The Org
BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat …See details»
BiomeBank Company Profile 2024: Valuation, Funding …
BiomeBank General Information Description. Operator of a biotechnology company intended to facilitate microbial therapies. The company uses a unique combination of machine learning and microbiology to identify bacterial strains …See details»
A biotechnology company announces the world’s first …
Nov 10, 2022 BiomeBank is a clinical stage biotechnology company located ... She has received the National Organization for Women Award and the National Council of Negro Women Achievement Award for her writing ...See details»
BiomeBank to scale up with $10.65 million capital raise
Dec 9, 2022 BiomeBank has multiple partnerships with leading research organisations, including research collaborations with the Hudson Institute of Medical Research and RMIT university for microbiome drug discovery and the …See details»
Innovating Health Solutions: The People Behind …
Feb 23, 2024 BiomeBank’s future outlook is shaped by a steadfast commitment to delivering microbiome therapies that redefine the therapeutic landscape. The company’s collaborative endeavors, technological ...See details»
BiomeBank, an Adelaide Australia-first, gets lab to take …
BiomeBank, Adelaide’s first purpose-built poo laboratory, opened in 2020 to start South Australia’s pioneering fight against debilitating gut conditions. BiomeBank, a partner of The Hospital Research Foundation Group, originated in Adelaide …See details»
Clinician - BiomeBank
Feb 21, 2024 BiomeBank’s microbiome-based therapy is the first microbiome-based therapy approved world wide. The product’s formulation includes syringes frozen for colonoscopy and enema delivery. Our products are manufactured in …See details»
BiomeBank - Contacts, Employees, Board Members, Advisors
BiomeBank is a clinical stage biotechnology company developing microbial therapiesSee details»
Ellerston Capital-backed BiomeBank needs people to donate their …
Dec 7, 2022 BiomeBank was founded in 2018 by Dr Costello, a gastroenterologist who has practised in both Adelaide and the UK. Dr Costello has been researching the use of fecal …See details»
BiomeBank Submits for Market Authorisation of World First …
Jun 30, 2021 Thomas Mitchell, BiomeBank CEO Ph: +61 411 911 775 E: [email protected] Abbey Bell, Communications Consultant Ph: +61 401 082 124 E: …See details»
BiomeBank Announces World First Regulatory Approval for Donor …
Nov 9, 2022 BiomeBank is a clinical stage biotechnology company developing a pipeline of microbiome-based therapies to treat unmet medical need. BiomeBank's mission is to treat and …See details»
BiomeBank Announces World First Regulatory Approval for Donor …
Nov 9, 2022 BiomeBank's Co-founder and Managing Director Dr Sam Costello said, "This approval is a landmark for BiomeBank and an important advance for microbiome therapeutics …See details»
Investing in BiomeBank - a leading biotechnology company
BiomeBank is well-positioned to become a global leader in the discovery and commercialisation of microbial therapies. Our current donor-derived therapy is the world’s first approved …See details»
Scaling Success: BiomeBank's Product Offerings Unlock the …
May 31, 2024 BiomeBank's donor-derived microbiome therapy, provides an alternative way of treating conditions like C. difficile infection than traditional treatment. With its approval by …See details»
BiomeBank Company Insight - Pharma Technology Focus | Issue …
Sep 20, 2024 BiomeBank's solution to this is the Consortiome platform, which can co-culture a diverse array of microbes, encompassing over 90% of the gene families and functions found in …See details»
BiomeBank - IMCRC
BiomeBank Chief Executive Officer Thomas Mitchell said the new technology enables BiomeBank to commercialise at scale, with reproducibility, which would not have been possible without the …See details»